A blocking antibody against canine CSF-1R maturated by limited CDR mutagenesis.

Antib Ther · 2020 · PMC7990251 · PMID 33937625

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The proliferation curve of mAb 3.1-treated macrophages was different from the isotype control at 1.25 μg/well (Holm–Sidak post hoc test) and showed a trend of significant activity at 3.75 and 7.5 μg/well (differences were only significant with a Fisher post hoc test).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.